HFpEF Pharmacological Management

Mai H Duong, Martha Gulati, Parag Goyal, et al

Read time: 31m 40s

Leo Gozdecki, Mark N Belkin

Read time: 10m
Practice‑Changing Therapies for HFpEF/HFmrEF: SGLT2i, MRAs and Incretin Trials

Harriette Van Spall, Maja Cikes

Watch time: 22m 28s

Athena Adeli, Revathy Sampath-Kumar, Anne Wang, et al

Read time: 28m 20s

Gregory Burkman, Gerald V Naccarelli

Read time: 28m 20s

Ann Marie Navar

Watch time: 4h 45m 40s (26 videos)

Nicolas M Van Mieghem, Azeem Latib

Watch time: 48m 3s (14 videos)
Early SGLT2i/MRA Use Benefits Suspected HF Patients

Cardiac Failure Review Journal

Hugo Prado-Prado, Sergio Raposeiras-Roubín

Read time: 8m 20s
February’s Top 10 Cardiology Resources: Videos and Essential Reads

Radcliffe Cardiology

Beta-Blockers Post-MI Show No Benefit in Preserved LVEF

Radcliffe Cardiology

Dominic Marcel Alfonso

Read time: 15m
Practice‑Changing Therapies for HFpEF/HFmrEF: SGLT2i, MRAs and Incretin Trials

Harriette Van Spall, Maja Cikes

Watch time: 22m 28s

Magdy Abdelhamid , Mostafa M Abdrabou, Emanuel Faris, et al

Read time: 16m

Ann Marie Navar

Watch time: 4h 45m 40s (26 videos)

Mai H Duong, Martha Gulati, Parag Goyal, et al

Read time: 31m 40s

Athena Adeli, Revathy Sampath-Kumar, Anne Wang, et al

Read time: 28m 20s

Chris J Kapelios, Bahira Shahim, Lars H Lund, et al

Read time: 18m

Leo Gozdecki, Mark N Belkin

Read time: 10m

Nicolas M Van Mieghem, Azeem Latib

Watch time: 48m 3s (14 videos)

Giulio Balestrieri, Raul Limonta, Enrico Ponti, et al

Read time: 18m 10s

Dung Viet Nguyen, Hoai Thi Thu Nguyen

Read time: 22m 13s

Gregory Burkman, Gerald V Naccarelli

Read time: 28m 20s

Andrew JS Coats, Silvio Inzucchi, Richard Hobbs, et al

Watch time: 1h 11m 54s (7 videos)

Media

Practice‑Changing Therapies for HFpEF/HFmrEF: SGLT2i, MRAs and Incretin Trials

Harriette Van Spall, Maja Cikes

Watch time: 22m 28s

Ann Marie Navar

Watch time: 4h 45m 40s (26 videos)

Nicolas M Van Mieghem, Azeem Latib

Watch time: 48m 3s (14 videos)
The Evolving Treatment Landscape for HFpEF in Cardiac Amyloidosis

Watch time: 6m 18s
AHA 25: Beta-Blocker Therapy Post MI in Patients with Preserved LVEF

Anna Meta Dyrvig Kristensen

Watch time: 5m 55s
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
ESC 25: Lifetime Benefits of Combination Therapy in HFpEF

Muthiah Vaduganathan

Watch time: 5m 6s
Cardiomyopathies: Management of Cardiomyopathies with Dr Michelle Kittleson

Michelle Kittleson

Watch time: 24m 40s
Prevention: What's New at HFA 2025?

Harriette Van Spall, Maja Cikes

Watch time: 10m 58s
ESCHFA25: FINEARTS-HF: Finerenone Risk-Benefit Across Kidney Function

Safia Chatur

Watch time: 5m 49s
ESC HF 25: Secondary Analysis of FINEARTS-HF

Ankeet Bhatt

Watch time: 5m 1s
THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s

Articles

New Insights on HFpEF Treatment

Giulio Balestrieri

,

Raul Limonta

,

Enrico Ponti

,

Anna Merlo

,

Edoardo Sciatti

,

Salvatore D’Isa

,

Mauro Gori

,

Gavino Casu

,

Cristina Giannattasio

,

Michele Senni

,

Emilia D’Elia

,

Published:

03 April 2024

Citation:

Cardiac Failure Review 2024;10:e05.

DOI:

https://doi.org/10.15420/cfr.2023.13
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 1025
  • Citations: 10
  • Read time: 18m 10s

The Burden of Disease of HFpEF

Chris J Kapelios

,

Bahira Shahim

,

Lars H Lund

,

Gianluigi Savarese

,

Published:

17 November 2023

Citation:

Cardiac Failure Review 2023;9:e14.

DOI:

https://doi.org/10.15420/cfr.2023.03
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 245
  • Citations: 73
  • Read time: 18m

Timing of SGLT2 Inhibitors in Heart Failure

Moritake Iguchi

,

Hiromichi Wada

,

Felipe Martínez

,

Koji Hasegawa

,

Published:

07 June 2023

Citation:

European Cardiology Review 2023;18:e41.

DOI:

https://doi.org/10.15420/ecr.2022.62
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 219
  • Citations: 3
  • Read time: 9m 20s

APSC Consensus Statements on Chronic Heart Failure

David Sim

,

Weiqin Lin

,

Andrew Sindone

,

Teerapat Yingchoncharoen

,

Hawani Sasmaya Prameswari

,

Azmee Mohd Ghazi

,

Lim Choon Pin

,

Louis Teo

,

Tar Choon Aw

,

Michael-Joseph Agbayani

,

Yuhui Zhang

,

Xinli Li

,

PB Jayagopal

,

Yuya Matsue

,

Seok-Min Kang

,

Yi-Heng Li

,

Michael Wong Ka Lam

,

Nguyen Quoc Thai

,

Jack WC Tan

,

Published:

11 April 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e10.

DOI:

https://doi.org/10.15420/japsc.2022.42
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 254
  • Citations: 12
  • Read time: 3m